Latest news and updates from sïParadigm Diagnostic Informatics
sïParadigm is proud to announce its selection as a Designated Laboratory for National Cancer Institute (NCI) Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice. This groundbreaking precision medicine study aims to evaluate effectiveness of new drug combinations for patients with advanced solid tumors based on unique genetic makeup of their tumors.
Read Full Press ReleaseBarry Kaplan, MD, PhD
Oncologist/Hematologist, Queens Medical Assoc.
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.
Contact Us
+1 888 599 LABS
Customer Service
cs@siparadigm.com
Have Questions or Concerns?
feedback@siparadigm.com
Careers
careers@siparadigm.com
Billing Inquiries
fap.billing@siparadigm.com
Unless otherwise noted, all content is CC-BY 2020 by siParadigm, LLC.